Clinical Trial Update: Hepatic Metabolism of Galactose and the Galactose Analog FDGal in Patients With Liver Disease and Healthy Subjects

View source ↗

Summary

A clinical trial evaluated hepatic metabolism of galactose and the galactose analog FDGal in patients with liver cirrhosis and in healthy subjects; the study ha…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Liver Cirrhosis

Drugs mentioned

• FDGal (FDGal)
• Galactose (galactose)

Snippet

Sponsor: Aarhus University Hospital | Conditions: Liver Cirrhosis | Status: COMPLETED